Recruiting
Interstitial lung disease+1
RecruitingAssessing Hemodynamic Effect and Safety of TX000045 in Adults with Pulmonary Hypertension Secondary to Interstitial Lung Disease
InvestigationalNo placebo
Assessing Hemodynamic Effect and Safety of TX000045 in Adults with Pulmonary Hypertension Secondary to Interstitial Lung Disease
InvestigationalNo placebo
- Disease:Interstitial lung diseasePulmonary hypertension
- Substances:TX000045
Countries:
Poland
Poland- Participants:18–64 years · 65+ years
- Substances:TX000045
- Sponsor:Tectonic Operating Company Inc.



